Mutasem Taha
Mutasem Taha
Professor of Drug Design, University of Jordan
Verified email at ju.edu.jo - Homepage
TitleCited byYear
Synthesis of chitosan succinate and chitosan phthalate and their evaluation as suggested matrices in orally administered, colon‐specific drug delivery systems
K Aiedeh, MO Taha
Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 1999
1251999
Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine
I Al-masri, KM Mohammad, MO Taha
journal of enzyme inhibition and medicinal chemistry 24 (5), 1061-1066, 2009
1192009
Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral …
K Aiedeh, MO Taha
European Journal of Pharmaceutical Sciences 13 (2), 159-168, 2001
1032001
Pharmacophore modeling, quantitative structure–activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3β inhibitory activities for …
MO Taha, Y Bustanji, MAS Al-Ghussein, M Mohammad, H Zalloum, ...
Journal of medicinal chemistry 51 (7), 2062-2077, 2008
902008
Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening
MO Taha, Y Bustanji, AG Al-Bakri, AM Yousef, WA Zalloum, IM Al-Masri, ...
Journal of Molecular Graphics and Modelling 25 (6), 870-884, 2007
882007
Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation
Y Bustanji, MO Taha, IM Almasri, MAS Al-Ghussein, MK Mohammad, ...
Journal of enzyme inhibition and medicinal chemistry 24 (3), 771-778, 2009
682009
Elaborate ligand-based pharmacophore exploration and QSAR analysis guide the synthesis of novel pyridinium-based potent β-secretase inhibitory leads
A Al-Nadaf, GA Sheikha, MO Taha
Bioorganic & medicinal chemistry 18 (9), 3088-3115, 2010
672010
Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening
IM Al‐masri, MK Mohammad, MO Taha
ChemMedChem: Chemistry Enabling Drug Discovery 3 (11), 1763-1779, 2008
622008
Combining ligand-based pharmacophore modeling, quantitative structure− activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive …
MO Taha, LA Dahabiyeh, Y Bustanji, H Zalloum, S Saleh
Journal of medicinal chemistry 51 (20), 6478-6494, 2008
612008
Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening
MO Taha, N Atallah, AG Al-Bakri, C Paradis-Bleau, H Zalloum, KS Younis, ...
Bioorganic & medicinal chemistry 16 (3), 1218-1235, 2008
582008
Discovery of potent inhibitors of pseudomonal quorum sensing via pharmacophore modeling and in silico screening
MO Taha, AG Al-Bakri, WA Zalloum
Bioorganic & medicinal chemistry letters 16 (22), 5902-5906, 2006
582006
Pharmacophore modeling, quantitative structure− activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors
AM Abu Hammad, MO Taha
Journal of chemical information and modeling 49 (4), 978-996, 2009
562009
Investigation of the active constituents of Portulaca oleraceae L.(Portulacaceae) growing in Jordan
AN Rasheed, FU Afifi, M Shaedah, MO Taha
Pakistan Journal of Pharmaceutical Sciences 17 (1), 37-45, 2004
562004
Ligand-based assessment of factor Xa binding site flexibility via elaborate pharmacophore exploration and genetic algorithm-based QSAR modeling
MO Taha, AM Qandil, DD Zaki, MA AlDamen
European journal of medicinal chemistry 40 (7), 701-727, 2005
552005
Docking-based comparative intermolecular contacts analysis as new 3-D QSAR concept for validating docking studies and in silico screening: NMT and GP inhibitors as case studies
MO Taha, M Habash, Z Al-Hadidi, A Al-Bakri, K Younis, S Sisan
Journal of chemical information and modeling 51 (3), 647-669, 2011
542011
Sodium lauryl sulfate impedes drug release from zinc-crosslinked alginate beads: Switching from enteric coating release into biphasic profiles
MO Taha, W Nasser, A Ardakani, HS AlKhatib
International Journal of Pharmaceutics 350 (1-2), 291-300, 2008
522008
Elaborate ligand-based modeling reveals new nanomolar heat shock protein 90α inhibitors
MA Al-Sha’er, MO Taha
Journal of chemical information and modeling 50 (9), 1706-1723, 2010
472010
Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration
RA Khalaf, GA Sheikha, Y Bustanji, MO Taha
European journal of medicinal chemistry 45 (4), 1598-1617, 2010
462010
Regression of endometrial implants treated with vitamin D3 in a rat model of endometriosis
MA Abbas, MO Taha, AM Disi, M Shomaf
European journal of pharmacology 715 (1-3), 72-75, 2013
442013
Pharmacophore and QSAR modeling of estrogen receptor β ligands and subsequent validation and in silico search for new hits
MO Taha, M Tarairah, H Zalloum, G Abu-Sheikha
Journal of Molecular Graphics and Modelling 28 (5), 383-400, 2010
412010
The system can't perform the operation now. Try again later.
Articles 1–20